Rights On Track—Astec Lifesciences Taps Shareholders for Growth Fuel

Unknown Apr 02, 2026 1,050 Views

Astec Lifesciences Ltd (NSE: ASTE.NS) has approved a rights issue of up to ₹2.50 billion, which is a strategic move in building its capital base and enable future growth plans. This was decided during the company's Board of Directors' meeting on June 24, 2025, as part of its overall strat...